BBNX
Beta Bionics
$15.99
+$0.14 (+0.88%)Jul 27, 2026
Key metrics
The numbers that frame BBNX today
- Market cap
- $712.54M
- P/E (TTM)
- -10.7
- EV / FCF
- -11.3
- Gross margin
- 57.2%
- EV / Sales
- 6.3
- ROIC
- -24.4%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $8.80
- 52wk High
- $32.71
Growth
Revenue and earnings trend for BBNX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BBNX
Is Beta Bionics a good buy?
Hold. Beta Bionics has strong momentum, but weak quality makes the setup mixed. Growth looks weak. That could put pressure on the long-term business case. We think Beta Bionics is selling at a very high price.
What is the market capitalization of BBNX?
Beta Bionics's market capitalization is $712.54M.
What is the P/E ratio for BBNX stock?
Beta Bionics's current P/E ratio is -10.7.
What is the 52-week high for BBNX stock?
The 52-week high for Beta Bionics is $32.71. The current close of $15.99 is 51.1% below that high.
What is the 52-week low for BBNX stock?
The 52-week low for Beta Bionics is $8.80. The current close of $15.99 is 81.7% above that low.
Does BBNX stock pay dividends?
Beta Bionics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BBNX?
Beta Bionics's Debt / Equity ratio is 0.03.